Discussion about risk and management of Chinese patent medicine with double identity / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 2249-2251, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-337950
ABSTRACT
Chinese patent medicine with double identity was a special phenomenon, and many preparations not only were prescription drugs but also over the counter ( OTC) drugs, which brought a lot of trouble. Based on statistics of list of OTC medicines of CFDA, related varieties, route of administration and functions of these drugs were searched. The causes of insufficient were analyzed and the potential risk was investigated. To ensure the safety of drug usage for the patient, risk management system should be set up by improving the technical requirements for registration, improving the drug labels and manuals, playing the role of pharmacists in pharmacy services and raising awareness of doctor and patient for these drugs.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Risk Management
/
China
/
Nonprescription Drugs
Type of study:
Etiology study
Limits:
Humans
Country/Region as subject:
Asia
Language:
Chinese
Journal:
China Journal of Chinese Materia Medica
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS